ENTITY
Kintor Pharmaceutical

Kintor Pharmaceutical (9939 HK)

67
Analysis
Health CareChina
Kintor Pharmaceutical Limited develops and markets drugs. The Company produces and sells androgen receptor antagonists, small molecule innovative drugs, and other products. Kintor Pharmaceutical markets its products primarily throughout China with limited overseas.
more
Refresh
21 May 2020 10:22

Kintor Pharma (开拓药业) IPO Trading: Limited Upside Despite Retail Chasing

Kintor Pharma raised HKD 1.7 billion (USD 225 m) from its global offering and will list on the stock exchange tomorrow. In our previous insights,...

Logo
210 Views
Share
17 May 2020 12:55

ECM Weekly (17 May 2020) -Dada Nexus, Kintor Pharma, Yeahka, Archosaur Games

Aequitas Research puts out a weekly update on the deals that have been covered by the team recently along with updates for upcoming...

Share
12 May 2020 14:57

Kintor Pharma IPO: Valuation Insights

Kintor Pharmaceutical (9939 HK) is a clinical-stage drug developer with a focus on potential first-in-class and best-in-class drugs for cancers and...

Logo
330 Views
Share
12 May 2020 10:19

Kintor Pharma (开拓药业) IPO: Weak in Cornerstone but Still Expect Upside

Kintor Pharma launched book building today to raise up to USD 240 million to listing in Hong Kong. Book will be closed swiftly on Friday. In our...

Logo
413 Views
Share
bullishKingsoft Cloud
10 May 2020 13:33

ECM Weekly (10 May 2020) - Kingsoft Cloud, NetEase, Central China New Life, Peijia Medical, Kintor,

Aequitas Research puts out a weekly update on the deals that have been covered by the team recently along with updates for upcoming IPOs. As...

Share
x